Literature DB >> 10721668

A nonsense mutation at Arg-1947 in the NF1 gene in a case of neurofibromatosis type 1 in a Korean patient.

K C Park1, H O Choi, K H Park, K H Kim, H C Eun.   

Abstract

We report a case of neurofibromatosis (NF) 1 presenting as a C-to-T transition changing an Arg-1947 codon to a stop codon. Because this mutation has been described in multiple Caucasian and Japanese families, the codon CGA for Arg-1947 in the NF1 gene is considered to be a hotspot for mutation in neurofibromatosis type 1 in all ethnic groups.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10721668     DOI: 10.1007/s100380050016

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  4 in total

1.  Clinical and molecular characteristics of thirty NF1 variants in Chinese patients with neurofibromatosis type 1.

Authors:  Wen Wang; Weibing Qin; Hongsong Ge; Xiangsheng Kong; Chao Xie; Yunge Tang; Ming Li
Journal:  Mol Biol Rep       Date:  2019-06-14       Impact factor: 2.316

2.  The spectrum of NF1 mutations in Korean patients with neurofibromatosis type 1.

Authors:  Seon-Yong Jeong; Sang-Jin Park; Hyon J Kim
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

3.  Mutational spectrum of NF1 gene in 24 unrelated Egyptian families with neurofibromatosis type 1.

Authors:  Nahla N Abdel-Aziz; Ghada Y El-Kamah; Rabab A Khairat; Hanan R Mohamed; Yehia Z Gad; Akmal M El-Ghor; Khalda S Amr
Journal:  Mol Genet Genomic Med       Date:  2021-06-03       Impact factor: 2.183

4.  Recurrent NF1 gene variants and their genotype/phenotype correlations in patients with Neurofibromatosis type I.

Authors:  Matteo Riva; Davide Martorana; Vera Uliana; Edoardo Caleffi; Elena Boschi; Livia Garavelli; Giovanni Ponti; Luca Sangiorgi; Claudio Graziano; Stefania Bigoni; Luca Maria Rocchetti; Simona Madeo; Fiorenza Soli; Enrico Grosso; Diana Carli; Matteo Goldoni; Francesco Pisani; Antonio Percesepe
Journal:  Genes Chromosomes Cancer       Date:  2021-09-03       Impact factor: 4.263

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.